Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Anticancer Res ; 19(5B): 3947-52, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10628336

RESUMO

The radical intensity of BHA (4-Hydroxy-3-t-butylanisole) and its dimer (3,3'-Di-t-butyl-5,5'-dimethoxy-1,1'-biphenyl-2,2'-diol, Bis-BHA) were compared with their cytotoxic activity. ESR spectroscopy showed that BHA produced characteristic five peaks of radicals under alkaline conditions (pH > 9.5). At higher pH, BHA radical rapidly disappeared, and progressively transformed into new radical species, as detected by the splitting of the ESR signal. BHA showed higher cytotoxic activity against salivary gland tumor cell line than against normal human gingival fibroblast. On the other hand, Bis-BHA did not produce any detectable amounts of radicals at wide ranges of pH, corresponding with its weaker cytotoxic activity as compared with BHA. BHA scavenged DPPH (1,1-Diphenyl-2-picrylhydrazyl) radical and superoxide anion, more efficiently than Bis-BHA. The present study demonstrated that BHA is more cytotoxic, produces higher amounts of radicals and more efficiently scavenges various radical species, as compared with Bis-BHA. This suggests the possible link between the cytotoxic activity and radical generation/scavenging activity in BHA-derived compounds.


Assuntos
Antioxidantes/química , Hidroxianisol Butilado/química , Hidroxianisol Butilado/farmacologia , Sequestradores de Radicais Livres/química , Picratos , Aspirina/farmacologia , Bepridil/análogos & derivados , Bepridil/farmacologia , Compostos de Bifenilo , Hidroxianisol Butilado/análogos & derivados , Criança , Relação Dose-Resposta a Droga , Espectroscopia de Ressonância de Spin Eletrônica , Feminino , Fibroblastos/metabolismo , Radicais Livres/química , Gengiva/metabolismo , Humanos , Concentração de Íons de Hidrogênio , Cinética , Modelos Químicos , Neoplasias das Glândulas Salivares/tratamento farmacológico , Fatores de Tempo , Células Tumorais Cultivadas
2.
In Vitro Cell Dev Biol Anim ; 35(3): 169-74, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10476914

RESUMO

The effect of phenolic compounds in foodstuffs on histamine and leukotriene B4 (LTB4) release from rat peritoneal exudate cells and their antioxidative activity were examined to assess their antiallergenic activities. Among them, triphenols such as pyrogallol and gallic acid inhibited histamine release from the cells, but diphenols did not. On the other hand, o- and p-diphenols such as catechol and hydroquinone with strong antioxidative activity inhibited LTB4 release as strongly as pyrogallol, but an m-derivative resorcinol with weak antioxidative activity did not. Though carboxylated compounds and their noncarboxylated counterparts were antioxidative, the former exerted a much weaker inhibitory effect on the LTB4 release than the latter. In flavonols, only myricetin with a triphenolic B ring strongly inhibited histamine release, but all flavonols strongly suppressed LTB4 release irrespective of the number of OH groups in the B ring. Among flavonoids with an o-diphenolic B ring, flavonol and flavone with a C4-carbonyl group strongly inhibited LTB4 release, whereas the activity of anthocyan without C4-carbonyl was much weaker than the above compounds. These results suggest that triphenolic structure is essential for the inhibition of histamine release. On the other hand, antioxidative activity and membrane permeability of phenolic compounds seemed to be essential for the inhibition of LTB4 release. In addition, the C4-carbonyl group seemed to be important for strongly inhibiting LTB4 release.


Assuntos
Liberação de Histamina , Leucotrieno B4/metabolismo , Fenóis/farmacologia , Picratos , Polímeros/farmacologia , Animais , Antioxidantes/farmacologia , Bepridil/análogos & derivados , Bepridil/farmacologia , Compostos de Bifenilo , Hidroxitolueno Butilado/farmacologia , Exsudatos e Transudatos , Flavonoides/farmacologia , Radicais Livres , Masculino , Peritônio/citologia , Fenóis/química , Fenóis/metabolismo , Polímeros/química , Polímeros/metabolismo , Ratos , Ratos Wistar , Relação Estrutura-Atividade , Vitamina E/farmacologia
3.
J Pharmacol Toxicol Methods ; 60(1): 39-44, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19442753

RESUMO

Inhibition of the human ether-a-go-go-related gene (hERG) potassium channel by pharmaceutical agents can lead to acquired long QT syndrome and the generation of potentially lethal arrhythmias. Higher throughput automated patch clamp systems, such as PatchXpress, can greatly increase the speed and capacity of evaluation of pharmaceutical compounds for hERG blocking activity. A factor that may affect the IC(50) value of a compound measured in this system is the composition of the multi-well compound plate. Hydrophobic compounds may adsorb to the surfaces of multi-well plates resulting in a reduction in the effective concentration of the compound delivered to the cell and altered IC(50) values. In the present study, we investigated the effects of four different compound plates--glass vials, non-binding polystyrene, hydrophilic polystyrene, and polystyrene--on determination of IC(50)s for four compounds--sotalol, dofetilide, cisapride, and bepridil--which ranged in hydrophobicity. In addition, we investigated the effects of incubation time in the compound plate on determination of IC(50)s. hERG currents were measured using the PatchXpress 7000A Automated Parallel Patch Clamp System (Molecular Devices Corporation; Sunnyvale, CA) and hERG channels stably expressed in HEK293 cells. The results suggest that more hydrophobic compounds may adsorb to non-binding polystyrene, hydrophilic, and polystyrene compound plates versus glass plates, especially with increasing time on the plates, resulting in altered IC(50) values.


Assuntos
Canais de Potássio Éter-A-Go-Go/antagonistas & inibidores , Canais de Potássio Éter-A-Go-Go/fisiologia , Vidro , Técnicas de Patch-Clamp/métodos , Poliestirenos , Adsorção , Bepridil/farmacologia , Linhagem Celular , Cisaprida/farmacologia , Humanos , Interações Hidrofóbicas e Hidrofílicas , Técnicas de Patch-Clamp/instrumentação , Fenetilaminas/farmacologia , Reprodutibilidade dos Testes , Sotalol/farmacologia , Sulfonamidas/farmacologia
4.
J Neurochem ; 63(6): 2136-43, 1994 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7964733

RESUMO

The inhibitory effects of Na+/Ca2+ exchange inhibitory peptide (XIP), which corresponds to residues 219-238 of the Na+/Ca2+ exchange protein from canine heart, were studied in both rat and human brain plasma membrane vesicles. XIP had very high potency with respect to the inhibition of the initial velocity of intravesicular Na(+)-dependent Ca2+ uptake in both rat brain [IC50 = 3.05 +/- 0.69 microM (mean +/- SE)] and human brain (IC50 = 3.58 +/- 0.58 microM). The maximal inhibition seen in rat brain vesicles was approximately 80%, whereas human brain vesicles were inhibited 100%. XIP also inhibited extravesicular Na(+)-dependent Ca2+ release, and the inhibitory effect was enhanced by increasing the extravesicular Na+ concentration. In contrast, the inhibitory effect of bepridil was competitive with respect to extravesicular Na+. When XIP was added at steady state (5 min after the initiation of intravesicular Na(+)-dependent Ca2+ uptake), it was found that the intravesicular Ca2+ content declined with time. Analysis of unidirectional fluxes for Ca2+ at steady state showed that 50 microM XIP inhibited Ca2+ influx and efflux approximately 85 and 70%, respectively. This result suggested that XIP inhibited both Na+/Ca2+ exchange and Ca2+/Ca2+ exchange but had no effect on the passive release pathway for Ca2+. The results suggest structural homology among cardiac, rat, and human brain exchangers in the XIP binding domain and that the binding of Na+ or other monovalent cations, e.g., K+, is required for XIP to have its inhibitory effect on Ca2+ transport.


Assuntos
Encéfalo/metabolismo , Cálcio/metabolismo , Peptídeos/farmacologia , Sódio/metabolismo , Sequência de Aminoácidos , Animais , Bepridil/farmacologia , Encéfalo/efeitos dos fármacos , Proteínas de Transporte/antagonistas & inibidores , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Permeabilidade da Membrana Celular/efeitos dos fármacos , Humanos , Lipossomos/metabolismo , Dados de Sequência Molecular , Peptídeos/química , Ratos , Sódio/farmacologia , Trocador de Sódio e Cálcio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA